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nflammation Causes Mood Changes Through
lterations in Subgenual Cingulate Activity
ndMesolimbic Connectivity
eil A. Harrison, Lena Brydon, Cicely Walker, Marcus A. Gray, Andrew Steptoe, and Hugo D. Critchley
ackground: Inflammatory cytokines are implicated in the pathophysiology of depression. In rodents, systemically administered inflam-
atory cytokines induce depression-like behavior. Similarly in humans, therapeutic interferon- induces clinical depression in a third of
atients. Conversely, patients with depression also show elevated pro-inflammatory cytokines.
bjectives: To determine the neural mechanisms underlying inflammation-associated mood change and modulatory effects on circuits
nvolved in mood homeostasis and affective processing.
ethods: In a double-blind, randomized crossover study, 16 healthy male volunteers received typhoid vaccination or saline (placebo)
njection in two experimental sessions. Mood questionnaires were completed at baseline and at 2 and 3 hours. Two hours after injection,
articipants performed an implicit emotional face perception task during functional magnetic resonance imaging. Analyses focused on
eurobiological correlates of inflammation-associated mood change and affective processing within regions responsive to emotional
xpressions and implicated in the etiology of depression.
esults: Typhoid but not placebo injection produced an inflammatory response indexed by increased circulating interleukin-6 and
ignificant mood reduction at 3 hours. Inflammation-associated mood deterioration correlated with enhanced activity within subgenual
nterior cingulate cortex (sACC) (a region implicated in the etiology of depression) during emotional face processing. Furthermore,
nflammation-associated mood change reduced connectivity of sACC to amygdala, medial prefrontal cortex, nucleus accumbens, and
uperior temporal sulcus, which was modulated by peripheral interleukin-6.
onclusions: Inflammation-associated mood deterioration is reflected in changes in sACC activity and functional connectivity during
voked responses to emotional stimuli. Peripheral cytokines modulate this mood-dependent sACC connectivity, suggesting a common
athophysiological basis for major depressive disorder and sickness-associated mood change and depression.ey Words: Cytokines, depression, fMRI, mood, peripheral inflam-
ation, subgenual cingulate
linical and animal studies implicate systemic inflammation
in the pathogenesis of depression (1). In healthy mam-
mals, systemic infection triggers profound behavioral
hanges, including cognitive and mood symptoms (e.g., memory
mpairment, anhedonia, anxiety, depression), change in motiva-
ion (anorexia, adipsia), and neurovegetative symptoms (sleep
isturbance, psychomotor slowing) (2–4) known as sickness
ehaviors. Animal and human studies suggest that inflammatory
ytokines play a central role in mediating these sickness-related
ehaviors by communicating peripheral inflammation to the
rain. These cytokine-induced sickness behaviors show a strik-
ng similarity to symptoms of major depression (5) and might
ccount for the high incidence of depression in medically ill
atients, particularly those with inflammation or immune activa-
ion secondary to infection, autoimmunity, tissue damage, or
alignancy.
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oi:10.1016/j.biopsych.2009.03.015In rodents, systemic administration of interleukin (IL)-1 or
bacterial lipopolysaccharide (LPS), a potent stimulant of cytokine
release, can rapidly elicit a depression-like syndrome character-
ized by a reduction in positively motivated approach behaviors
such as exploration, social interaction, and in operant behaviors
for food reward (6–9). Similarly experimental induction of
inflammation in healthy human subjects with either LPS (4) or
typhoid vaccination (10,11) acutely induces symptoms of fatigue,
psychomotor slowing, mild cognitive confusion, memory impair-
ment, anxiety, and deterioration in mood that mirror features of
depression. Furthermore, patients receiving more prolonged or
repeated therapeutic administration of interferon (IFN)- show
that inflammatory cytokines induce true major depressive epi-
sodes in up to 50% of individuals (12). Moreover, in patients with
major depressive disorder (MDD), the presence of high levels of
pro-inflammatory cytokines (in particular IL-6) (13) and acute
phase proteins (14) suggest that inflammatory mediators might
contribute to the pathophysiology of depression even in the
absence of medical illness.
Depression is increasingly recognized to be a multi-compo-
nential disorder involving motivational change; cognitive, atten-
tion, memory, and mood disturbance; and biological features
such as disturbed appetite, sleep, and sexual dysfunction. It is
therefore interesting that separate features of clinical depression
induced by repeated administration of IFN- over many weeks
seem to develop with characteristic time-courses (12,15). “Neu-
rovegetative” symptoms such as fatigue, psychomotor slowing,
anorexia, and impaired sleep develop early, typically within 2
weeks of initiation of IFN- therapy (12), whereas subjective
reports of depressed mood, anhedonia, anxiety, irritability, mem-
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wry, and attentional disturbance assessed with clinical depression
cales usually develop later, between the first and third months
f IFN- therapy (12). The neurobiological basis for differential
volution of individual features of inflammation-associated clin-
cal depression is currently uncertain; however, the ability of
cute inflammation to rapidly induce multiple depression-like
ymptoms suggests that the immune system can rapidly modu-
ate neuronal circuits central to the organization and reorganiza-
ion of complex motivational behavior that might lead to the
stablishment of mood disorder.
In a separate report published in this journal, we use func-
ional magnetic resonance imaging (fMRI) to show that Salmo-
ella typhi vaccine-induced inflammation modulates activity
ithin the hierarchy of brain regions representing internal bodily
tate (16). These observations in human participants are consis-
ent with rodent studies that suggest cytokines act on autonomic
fferent nerves to mediate motivational reorientation during the
arly phase of inflammation (17,18). Furthermore, this and
nother recent study showed that fatigue and psychomotor
lowing were associated with corresponding changes in activity
ithin insula (16) and substantia nigra (19).
The current study was designed to investigate the neurobio-
ogical mechanisms through which inflammation induces an
cute deterioration in mood, via effects on emotional processing.
n particular, we wished to investigate whether inflammation-
ssociated deterioration in mood recruited circuits implicated in
he pathophysiology of depression. As a model of emotional
rocessing we chose a variation of a face perception task that is
nown to activate the amygdala, superior temporal sulci (STS),
nd fusiform cortex in a mood-dependent manner (20).
ethods andMaterials
Sixteen healthy male students, mean age ( SD) 24.9 ( 4.8)
ears, were recruited from University College London (UCL)
ampus advertisements. Ten were Caucasian, 3 Indian-Asian, 2
hinese-Asian, and 1 Latin-American. Volunteers were reviewed
y a psychiatrist (NAH) and screened for a history of any relevant
igure 1. Study timeline. Participants completed mood rating questionnai
eceived Salmonella typhi capsular polysaccharide vaccination (Typhim V
njection on two separate occasions 1 week apart. Two hours after injectio
acial emotion recognition task during functional magnetic resonance ima
eproduced with permission from the Section of Psychology, Department of Clin
ww.sobp.org/journalphysical or psychiatric illness. One participant had a history of
hay fever, and another had shellfish allergy. Four participants
rated their general health as excellent, 7 very good, and 5 good.
No participant rated their general health as poor or fair. All were
medication free, with no nonsteroidal or steroidal inflammatory
drug use in the preceding 2 weeks, and were nonsmokers.
Volunteers who had received typhoid vaccine within 3 years or
other vaccine within 6 months were excluded. Participants were
advised to not consume caffeinated beverages or alcohol, avoid
high-fat meals, and refrain from excessive exercise for 12 hours
before testing. They were asked not to take aspirin, ibuprofen, or
antibiotics for 14 days before testing. After complete description
of the study to the subjects, written informed consent was
obtained. Procedures were approved by the joint UCL/UCL
Hospital Ethics Committee. Findings in the same group of
participants are also reported elsewhere (19,16).
We adopted a randomized, double-blind, cross-over repeated
measures design in which all participants underwent imaging in
two separate sessions, an average of 7 days apart as reported
previously (16). In the first session participants were randomly
assigned to one of two experimental conditions (typhoid vaccine
or placebo). Baseline blood sample was taken; then injections of
.025 mg of Salmonella typhi capsular polysaccharide vaccine
(Typhim Vi, Aventis Pasteur MSD, Berkshire, United Kingdom)
or .5 mL of normal saline placebo were administered intramus-
cularly into the deltoid muscle. An fMRI was performed 2 hours
after injection in a 60-min session. During each session, partici-
pants performed three tasks. This article focuses on data acquired
during an implicit facial-affect processing task. Immediately after
scanning, a second blood sample was taken (3 hours after injection)
for cytokine measurement. Body temperature was assessed at
baseline and at 2 and 3 hours with a sublingual digital thermometer.
See Figure 1 for study timeline. The second session was identical
except that participants received the other injection (i.e., typhoid
vaccination if they previously received saline and vice versa).
Mood and other psychological symptoms were assessed with
a modified version of the Profile of Mood States (POMS) (21).
rofile of Mood States [POMS]) and underwent venesection, then randomly
ntis Pasteur MSD, Berkshire, United Kingdom) or normal saline placebo
ticipants completed a flashing checkerboard control task, then an implicit
. The POMS and venesection were repeated at 3 hours. Facial expressionsres (P
i, Ave
n, par
gingical Neuroscience, Karolinska Institutet, Stockholm, Sweden (23).
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N.A. Harrison et al. BIOL PSYCHIATRY 2009;66:407–414 409his consisted of 36 items, each of which was rated on a
ive-point scale (0  not at all to 4  extremely). Six items were
aken from the vigor, tension-anxiety, depression-dejection, and
onfusion scales of the POMS and five from the fatigue scale. In
ddition, there were four symptom (feverish, aching joints, nause-
ted, and headache) and three filler items. Participants were asked
o rate how they felt at that moment. Scores for the five POMS
ubscales were computed by summing ratings on individual items.
otal mood scores were derived by the standard method detailed in
he POMS ratingmanual of subtracting ratings on the negative scales
tension-anxiety, depression-dejection, confusion, and fatigue) from
he vigor scores (21). Of note, this method produces a composite
otal mood score that is sensitive to changes in cognitive-mood and
eurovegetative contributions to mood.
We adopted a model of mild experimental inflammation with
tandard typhoid (Salmonella typhi) vaccination that has previ-
usly been shown to induce both a low-grade toll-like-receptor-4
ediated inflammatory-cytokine response (associated with an
pproximate doubling of peripheral IL-6 levels peaking between
and 3 hours) (22) and a transient negative total mood (peaking
.5–3 hours after injection) (10,11). Injection of .025 mg Salmo-
ella typhi vaccine (Typhim Vi, Aventis Pasteur MSD) or .9%
odium chloride placebo in identical 2-mL syringes was admin-
stered intramuscularly into the deltoid muscle by a qualified
octor (NAH). There were no complications of either injection.
Separate venepunctures were performed at baseline and 3
ours after injection for vaccine and placebo conditions. Blood
10 mL) was drawn into Vacutainer tubes (Becton Dickinson and
ompany, Franklin Lakes, New Jersey) containing ethylenedia-
inetetraacetic acid (EDTA) anticoagulant, centrifuged immedi-
tely at 1250 g for 10 min at room temperature. Plasma was
emoved, aliquoted, and frozen at70°C before analysis. Plasma
L-6 and tumor necrosis factor  (TNF-) were assessed with
igh-sensitivity, two-site enzyme-linked immunosorbent assays
ELISAs) (R&D Systems, Oxford, United Kingdom). The limit of
etection of the IL-6 assay was .09 pg/mL, with intra- and
nterassay coefficients of variation (CVs) of 5.3% and 9.2%,
espectively. The TNF- assay had a detection limit of .10 pg/mL
ith intra- and interassay CVs of 6.9% and 8.4%, respectively.
lasma IL-1RA concentrations were determined by a commercial
LISA from R&D Systems. This assay had a limit of detection of
5 pg/mL and inter- and intra-assay CVs of 10%. Salivary
ortisol was collected with cotton dental rolls at baseline and at
and 3 hours (Salivettes, Sarstedt, Leicester, United Kingdom)
nd analyzed with a time resolved immunoassay with fluores-
ence detection. Intra- and interassay variability were 8%.
Twenty faces (10 male) from a standardized series of facial
motional expressions (Karolinska-Directed-Emotional-Faces-
et [KDEF]) (23) were selected displaying happy, sad, angry, and
eutral expressions. Each face was presented for 500 msec in
andom order with an intertrial interval of 3400 msec. Each
dentity-expression combination was presented 4 times, along
ith 48 baseline trials (cross hair fixation). The same stimulation
et was used after both vaccine and normal saline placebo
njection. Participants performed an incidental age judgment
ask: indicating with a right-handed response pad if older or
ounger than 25 years of age. An orthogonal task and short
timulus presentation were chosen to elicit incidental affective
rocessing that previous data suggest might precede explicit
rocessing (24).
Gradient-echo single-shot echo planar imaging was used to
cquire T2*-weighted image volumes on a 1.5-T Siemens Sonata
Siemens AG Medical Solutions, Erlangen, Germany) scannerequipped with a standard head-coil. External restraint was used
to minimize head movement. We acquired 284 volumes each
with 44 slices (contiguous 2-mm slices with 1-mm inter-slice gap,
echo-time 40 msec: spatial resolution 3 mm  3 mm  3 mm).
Slices were tilted 30° from the intercommissural plane to
reduce orbitofrontal dropout due to susceptibility artifact from
frontal sinuses (25). High-resolution inversion-recovery echo
planar images were also obtained to aid image registration.
The fMRI data were analyzed with SPM5 (http://www.fil.ion.
ucl.ac.uk/spm). The first 5 volumes were discarded to allow for
T1 equilibration. Individual scans were realigned, unwarped,
normalized, and spatially smoothed with an 8-mm full-width-at-
half-maximal Gaussian kernel with standard SPM methods. High-
pass frequency filter (cut-off 120 sec) and corrections for auto-
correlation between consecutive scans (auto-regressive [AR]1)
were applied to the time series. Each event was modeled by a
standard synthetic hemodynamic response function at each
voxel across the whole brain. Presentations of neutral, happy,
sad, and angry facial expressions were modeled as separate
regressors. Null events (15% of presentations) were included to
facilitate identification of hemodynamic responses to stochasti-
cally ordered stimuli.
First-level individualized design matrices were estimated in
the following manner: effects of task (viewing happy, sad, angry,
and neutral facial expressions) were computed on a voxel-wise
basis for each participant for both vaccination and placebo
conditions in the form of SPMs of discrete contrasts within the
general linear model. Subsequent second-level analyses were
performed on the SPM contrast images with a 4 (emotional
expression)  2 (inflammatory status) factorial design to permit
formal inferences about population effects.
The main effect of viewing facial expressions (across both
vaccine and placebo conditions) was calculated within a second-
level analysis of variance encompassing individual contrasts for
each of the emotional expressions. Functionally activated clus-
ters in bilateral fusiform gyrus (fusiform face area [FFA]) and STS
were identified at a family-wise error corrected threshold (FWE)
of p  .05 and extracted with the image analysis package
MarsBaR (26). Anatomical localizers from the same package were
used for the amygdala bilaterally. Effects of inflammation on
activity in each of these regions was determined by extracting the
contrast estimates from the peak voxel in each region and
analyzing it in a 4 (emotional expression)  2 (inflammatory
status) repeated measures analysis of variance in SPSS (SPSS,
Chicago, Illinois).
We then performed a between-subject analysis to determine
regions in which response to implicit observation of emotional
facial expressions was modulated as a function of inflammation-
associated total mood change. This whole brain regression analysis
was performed with individual activation maps to facial emotional
expressions (vs. implicit baseline) with inflammation-associated
mood change as the between-subject dependent variable. Results
are reported for the STS, FFA, and amygdala at uncorrected and
stringent small volume FWE corrected thresholds.
We extended this approach to determine the effects of
inflammation-associated mood change on brain regions previ-
ously implicated in the etiology of depression, targeting specific
cortical (sACC, medial prefrontal, anterior cingulate) and subcor-
tical (thalamus, nucleus accumbens) regions of interest, informed
by prior research by Mayberg et al. (27) and others. This whole
brain between-subject regression analysis (with inflammation-
associated total mood change as the dependent variable) iden-
tified bilateral sACC as the region showing the strongest positive
www.sobp.org/journal
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worrelation with inflammation-associated deterioration in total
ood in keeping with previous analyses on the neurobiological
asis of depression (27) and anhedonia (28). Of note, no region
utside of this predefined region of interest showed a significant
orrelation with inflammation-associated mood change at an
ncorrected threshold of p  .001, 10 contiguous voxels.
We next performed an effective connectivity analysis to test
or changes in interregional neural connectivity related to the
sychophysiological interaction (PPI) between activity in sACC
physiological variable) and reported changes in total mood
psychological variable) (i.e., which brain regions increase or
ecrease their connectivity to sACC in a mood-dependent man-
er). Results are reported for uncorrected and stringent whole
rain or region of interest FEW-corrected for multiple compari-
ons. Finally we used peripheral cytokine response (IL-6), as an
ndex of peripheral inflammation, in correlational analyses to
etermine the influence of peripheral cytokines on emotional
ace processing, its interactions with inflammation-associated
ood change, and mood-dependent connectivity of sACC.
esults
Participants showed a significantly greater increase in serum
L-6 at 3 hours after typhoid vaccination compared with placebo
njection (mean difference [ SE] vaccine 1.00 [ .21] pmol/L vs.
lacebo .27 [ .13] pmol/L) [paired t (15)  2.84, p  .01],
onfirming a robust inflammatory response. Increase in serum
L-1RA and TNF- after vaccine did not reach significance, p 
05 (see Figure 1 in our accompanying article [16]). No subject
ad previously received typhoid vaccination, so these reflect
rimary immune responses. Changes in salivary cortisol and core
ody temperature with time were not significantly different
etween vaccination and typhoid conditions, although both
howed significant reduction with time in both conditions (see
upplement 1 in accompanying [16]). Of note, this temperature
eduction likely resulted from being in a cool scanning environ-
ent for 1 hour. Mean change salivary cortisol ( SE): vaccine
2.85 ( 3.31) nmol/L, placebo 5.63 ( 1.76) nmol/L [paired
(15)  .71, p  .49]. Mean change body temperature: vaccine
.71°C ( .14°C), Placebo .46°C ( .19°C) [paired t (15) 
.13, p  .28].
Participants reported a significant deterioration in total mood
hours after vaccination [single-tailed paired t (15)  1.86, p 
Table 1. Regions Responsive to Emotional Faces
Side Region (MNI)
Coordinates
(x y z)
Predicted ROI
R fusiform gyrus 36 62
L fusiform gyrus 42 58
L STS 54 56
R STS 54 38
L amygdala Anatomical ROI
R amygdala Anatomical ROI
Other Activated Regions
R DLPFC 48 44
L 1° Sensori-motor cortex 44 22
Bi primary visual cortex 6 90
L premotor and DAC 4 8
R cingulum 16 28
R insula 38 14
MNI, Montreal Neurological Institute; FWE, family wi
DLPFC, dorsolateral prefrontal cortex; DAC, dorsal anterior cin
ww.sobp.org/journal.041] but not after placebo [t (15) 1.43 p ns]; this accords with
findings in two previous studies reporting POMS total mood
responses to typhoid vaccination (10,11). At baseline subjects
showed a high positive vigor score coupled with low ratings on
negative scales, indicating that participants were generally in
positive moods. More negative total mood was associated with
higher trait anxiety, as has been observed previously (10).
Examination of the subscales contributing to the POMS total
mood score showed that inflammation-associated change in total
mood score was driven by an increase in both mood/cognitive
(confusion) and neurovegetative (fatigue) symptoms. Smaller
contributions to change in total mood score came from an
increase in inflammation-associated tension-anxiety. Changes in
depression-dejection and vigor subscales showed little contribu-
tion suggesting that inflammation-associated changes in total
mood largely reflected increases in confusion, fatigue, and to a
lesser extent tension-anxiety rather than depression-dejection or
vigor (see Supplement 1 in [16]). Although we did not observe a
significant linear correlation between total mood change and
magnitude of IL-6 response, there was a trend toward a greater
deterioration in mood in those individuals with the greatest IL-6
responses [T(15)  1.77, p  .099, r  .43]. There was no
effect of vaccine on ratings of illness symptoms, including fever,
nausea, aching joints, or headache.
Viewing all facial expressions (across placebo and vaccine
conditions combined) activated the brain regions supporting
emotional face perception, including face-selective fusiform cor-
tex (29), superior temporal sulci, and bilateral amygdala (Table
1). Additional task–specific activations at the same stringent
FEW-corrected threshold, p  .05, were seen in primary visual,
sensorimotor, insula, premotor, dorsal anterior cingulate, and
right dorsolateral prefrontal cortices (DLPFC).
Emotional compared with neutral expressions were associ-
ated with significantly greater activity in the left amygdala and
bilateral superior temporal sulci, regions previously implicated in
viewing emotionally valenced faces. There was no significant
difference in activity in face-selective regions of fusiform cortex
(Table 2), consistent with the incidental nature of the task.
Secondary emotional enhancement of fusiform face cortex activ-
ity is largely task-dependent, with some studies reporting an
effect (30) and others none (31). Inflammation had a marginally
significant effect on right-sided STS responses to viewing emo-
Z
Score
Uncorrected
p
Whole Brain
Corrected (FWE) p
8 .001 .05
7.79 .001 .05
5.86 .001 .05
4.99 .001 .05
5.17 .001 .05
4.57 .001 .05
7.41 .001 .05
7.11 .001 .05
7.01 .001 .05
6.86 .001 .05
5.94 .001 .05
5.27 .001 .05
or; ROI, region of interest; STS, superior temporal sulcus;20
24
14
8
10
60
8
56
10
8
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N.A. Harrison et al. BIOL PSYCHIATRY 2009;66:407–414 411ional facial expressions [F (15,1)  4.37, p  .055] with no
ignificant influence on activity in any of the other face response
egions reported in Table 1.
The significant deterioration in total mood after inflammation
ut not placebo at 3 hours was highly correlated with enhance-
ent of evoked responses to emotional facial expressions within
he sACC (including cytoarchitectonically defined Cg25), Montreal
eurological Institute (MNI) coordinates (2, 22, 28) (Figures 2A
nd 2B, Table 3). This region is critically implicated in neurobiolog-
cal mechanisms of depression and the target for successful treat-
ent of depression with deep brain stimulation (Figure 2C). Activity
ithin amygdala, a key region in processing emotional information
rom faces, was correspondingly attenuated (Table 1). The sACC
ctivity reflected the interaction between processing of emotional
acial expressions and inflammation-associated total mood change
ather than as a main effect of processing emotional faces.
We extended the investigation of this interaction with a
onnectivity analytic approach (PPI). Specifically, we first deter-
Table 2. Modulation in Face Responsive Regions to Em
Side Region (a)
Emotion Neutral ROI
Coordinates
(x y z) Sc
L STS (56, 46, 4) 2
R STS (58, 32, 0) 3
L amygdala (28, 2, 18) 3
R	L fusiform face area
STS, superior temporal sulcus.
aCluster size at uncorrected p value reported in the t
igure2. Subgenual cingulate (subgenual anterior cingulate cortex [sACC], C
ubgenual cingulate (Cg25), which shows the strongest prediction of inflam
-mm diameter region of interest centered on the peak subgenual cingulat
abscissa). (C) Area of placement of deep brain stimulation electrodes for th
ctivation shown in A. Reprinted from Neuron, volume 45, Mayberg et al., “
005, with permission from Elsevier (27).mined brain regions where activity change to processing emo-
tional faces correlated with sACC activity (effective connectivity),
then examined how inflammation-associated total mood change
modulated connectivity to sACC (Table 3). Individuals who
experienced the greatest deterioration in total mood after periph-
eral inflammation showed a highly significant reduction in the
functional relationship between sACC and activity within anterior
rostral medial prefrontal cortex (arMPFC), (Brodmann area [BA]32,
BA10), MNI coordinates (10, 48, 8), nucleus accumbens (Figures
3B and 3A, respectively), right amygdala, STS (Figure 3C), and
FFAs. No a priori region in mood-related circuits showed in-
creased connectivity to sACC with enhanced depression.
Finally we investigated whether peripheral inflammatory cy-
tokine levels (IL-6) influenced sACC activity or its mood-depen-
dent connectivity. Although circulating IL-6 level did not corre-
late with neural responses to emotional faces within sACC
directly (or any other brain region), it did show a modulatory
influence on the mood-dependent connectivity of sACC to right
al Expression
K
Clustera
Uncorrected
p
Small Volume
Corrected p
10 .002 .07
20 .001 .05
29 .001 .05
ns ns
activity predicts inflammation-associated totalmood change. (A)Regionof
ion-associated deterioration in total mood. (B) Correlation of activity in an
el (2, 22–28) (ordinate) with inflammation-associated total mood change
tment of primary depression (27) showing relative position with respect to
brain stimulation for treatment-resistant depression,” 651–660, copyrightotion
Z
ore
.85
.21
.50
nsg25)
mat
e vox
e trea
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wmygdala (R2 .49, p .004), nucleus accumbens (R2 .33, p
025), arMPFC (R2  .37, p  .016), and right STS (R2  .31, p 
032).
iscussion
The results of this study illustrate that experimental inflam-
ation induced by typhoid vaccination produces a robust in-
rease in pro-inflammatory cytokines (IL-6) and reduction in a
omposite measure of mood (that includes both cognitive-mood
nd neurovegetative contributions) in normal healthy male vol-
nteers at 3 hours. This was not associated with an increase in
emperature or salivary cortisol or ratings of illness symptoms,
Table 3. Regions Whose Activity and Connectivity to sA
Side Region
Coordinates
(x y z)
Activitya
R	L sACC (Cg25) (2, 22, 8)
L amygdala (14, 8, 28)
Connectivityb
R	L medial frontal gyrus (10, 48, 8)
L nucleus accumbens (10, 2, 10)
R fusiform face area (44, 48, 16)
R STS (62, 20, 0)
R amygdala (26, 6, 18)
R2 values correspond to peak voxel.
sACC, subgenual anterior cingulate cortex; STS, supe
aInflammation-induced mood change.
bFunctional connectivity to subgenual cingulate (Cg
cWhole brain family wise error-corrected p value.
igure 3. Psychophysiological interaction between inflammation-associate
ssociated change in total mood correlates with reduction in connectivity
nterior rostral medial prefrontal cortex showing reduced connectivity t
nflammation-associated change in total mood correlates with reduced subgenu
ww.sobp.org/journalincluding fever, nausea, and aching joints, suggesting that the
reduction in total mood is likely a direct result of associated
cytokine responses. As has been observed previously, greater
sensitivity to inflammation-associated deterioration in this mood
measure was associated with higher trait-anxiety (10). This is in
keeping with the broader literature on predisposing factors for
clinical depression (32) and studies of IFN-–induced depression
where personality traits predict patients most at risk of develop-
ing depression during treatment of hepatitis C or malignant
melanoma (33).
Evidence from functional brain imaging, therapeutic, and
lesion studies have led to a conceptualization of depression as a
redicts Inflammation-Associated Mood Change
Z
ore R
Uncorrected
p
Small Volume
Corrected p
.29 .55 .001 .05
.39 .57 .001 .07
.21 .88 .001 .05c
.99 .85 .001 .05
.15 .51 .001 ns
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N.A. Harrison et al. BIOL PSYCHIATRY 2009;66:407–414 413ultidimensional systems level disorder affecting discrete but
unctionally integrated pathways (34,35). The sACC has become
ncreasingly recognized as a key node in functional and anatom-
cal models of mood regulation (36) and coordination of emo-
ional processing. It is also strongly implicated in the pathophys-
ology of MDD (37). Increased sACC activity seen in depression
as also been shown to reverse with successful depression
reatment with a selective serotonin reuptake inhibitor (38,39),
eep brain stimulation (27,40) of adjacent white matter tracts,
nd even placebo (39). It is therefore striking that inflammation-
ssociated deterioration in total mood correlated with activity
voked by emotional facial expressions in sACC. These early
ood-dependent changes in sACC activity occurring within 3
ours of inflammatory challenge suggest that inflammation-
ssociated changes in this composite mood measure recruits
eural circuitry similar to that implicated in primary depression.
his is also supported by the responsiveness of cytokine-related
ood changes to selective serotonin reuptake inhibitor treat-
ent.
Our connectivity analysis showed that—consistent with the-
retical models of mood regulation—inflammation-associated
hanges in total mood modulated the connectivity of sACC and
ucleus accumbens with reduction in effective interconnectivity
redicting greater deterioration in total mood. These findings
upport animal studies showing that inflammation-associated
eduction in positively motivated, depression-like behavior cor-
elates with reduced nucleus accumbens activity (8). The mood-
ependent modulation of nucleus accumbens activity in our
tudy highlights a potential mechanism for inflammation-in-
uced modulation of hedonic tone through changes in sACC
nfluences on reward-related brain regions and might underlie
nhedonia, another core feature of depression (28).
Inflammation-associated deterioration in total mood was also
ssociated with a marked decrease in activity within amygdala, a
egion central to processing emotional information from faces.
onnectivity analysis also showed that inflammation-associated
ood change modulated the connectivity between sACC and
rMPFC, a region activated when thinking about others, and with
ight STS and amygdala, regions implicated in processing social/
motional information from faces. These changes might under-
in the marked reduction in social behavior associated with
cute sickness, possibly reflecting an internal self-reorientation of
ttentional focus (9) and the heterogeneity of symptoms associ-
ted with inflammation-associated mood change. Interestingly,
epression is typically associated with an increase in amygdala
ctivity (41) to emotional faces (42), suggesting that sustained
ood change might modulate connectivity within this circuitry. It
s noteworthy that our composite measure of mood change that
as sensitive to heterogeneous mood-related symptoms also
evealed modulation of activity within a network of regions
onnected to sACC, a region itself implicated in integrating
ultiple components of mood homeostasis. Future studies
hould focus on whether differential influences of inflammation
n each of these circuits underlie differences in the temporal
volution of individual components of depression associated
ith repeated and prolonged cytokine administration.
In the present study, the correlation between peripheral
ytokine levels (IL-6) and inflammation-associated mood deteri-
ration did not reach significance, although there was a trend for
hose subjects showing the greatest IL-6 response to report a
reater deterioration in total mood [t (15)  1.77, p  .099, r 
.43]. Previously, Wright et al. (11) showed a significant corre-ation between IL-6 response and subjective mood deteriorationwith a similar effect size with the same typhoid vaccination
inflammatory model and POMS total mood score. However, this
study used a larger sample of 30 healthy male volunteers. The
evoked inflammatory responses in our study also did not directly
predict changes in the magnitude of activity within sACC, a
reported observation for TNF- responses to inflammatory chal-
lenge in subjects with asthma (43). However, IL-6 responses did
influence the mood-dependent connectivity of sACC with amyg-
dala, arMPFC, nucleus accumbens, and STS, suggesting that
inflammation-associated deterioration in total mood arose
though the modulation of sACC connectivity with regulatory
centers for reward, emotion, and social processing. It is plausible
that a more direct influence of peripheral inflammatory media-
tors on sACC activity might have been obscured by constitutional
differences of participants, including gender and age (our current
study was performed in young healthy male subjects, whereas
the study population of Rosenkranz et al. [43] in asthma subjects
was 50% female). This question will need to be addressed in
future studies performed in larger and more heterogeneous
populations.
Our findings provide a mechanistic neurobiological account
for heterogeneous mood-related components of sickness behav-
ior and suggest a common pathophysiological basis for MDD and
sickness-associated mood change and depression. Putatively,
these observations imply that the central neurobiological circuits
supporting adaptive motivational reorientation during sickness
might be “hijacked” maladaptively during clinical depression.
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